These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1300804)

  • 21. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cardiotropic activity of synthetic peptide CH3CO-Lys-Lys-Arg-Arg-NH2 (protectin)].
    Sazhin AI; Zaĭtseva MA; Melikhova ME; Ezhov NF; Sadovnikov VB; Navolotskaia EV
    Eksp Klin Farmakol; 2011; 74(6):14-9. PubMed ID: 21870769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The immunomodulating action of riboxin during physical loading].
    Laskova IL; Uteshev BS
    Eksp Klin Farmakol; 1992; 55(5):48-50. PubMed ID: 1305453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Carcinogenesis-modifying properties of aniline, carbon tetrachloride, benzene and ethanol].
    Litvinov NN; Voronin VM; Kazachkov VI
    Eksp Onkol; 1986; 8(2):21-3. PubMed ID: 3698878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of the duration of benz(a)pyrene exposure and the size of the 1-time dose on the nature and intensity of the carcinogenic reaction].
    Ianysheva NIa; Chernichenko IA; Balenko NV; Pavlova NA
    Gig Sanit; 1980 Dec; (12):14-7. PubMed ID: 7203058
    [No Abstract]   [Full Text] [Related]  

  • 26. [The mechanism of action of riboxin].
    Dunaev VV; Tishkin VS; Evdokimov EI; Belaĭ IM
    Farmakol Toksikol; 1989; 52(6):56-8. PubMed ID: 2483141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The carcinogenic and anticarcinogenic properties of neozon D].
    Pliss GB; Vlasov NN; Zabezhinskiĭ MA
    Vopr Onkol; 1991; 37(1):60-4. PubMed ID: 2014680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of animal carcinogenicity experiments with multiple tumor types.
    Lu Y; Malani HM
    Biometrics; 1995 Mar; 51(1):73-86. PubMed ID: 7766797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinogenicity of captan.
    Reuber MD
    J Environ Pathol Toxicol Oncol; 1989; 9(2):127-43. PubMed ID: 2732908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dependence of the carcinogenic effect of N-nitrosomethylurea on its dosage and the age of female rats].
    Anisimov VN
    Vopr Onkol; 1987; 33(1):65-72. PubMed ID: 3811313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic toxicity study of cyclohexanone in rats and mice.
    Lijinsky W; Kovatch RM
    J Natl Cancer Inst; 1986 Oct; 77(4):941-9. PubMed ID: 3463822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the carcinogenic effect of ceramic fibers in experiments on rats and mice].
    Krajnow A; Lao I; Stetkiewicz J
    Med Pr; 1997; 48(6):663-74. PubMed ID: 9558634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Experimental study of the blastomogenic properties of the disperse dye fast yellow 4K].
    Kuz'menko NM; Petrovskaia OG
    Gig Sanit; 1983 Jul; (7):6-8. PubMed ID: 6618228
    [No Abstract]   [Full Text] [Related]  

  • 35. Neoplastic response of F344 rats and B6C3F1 mice to the polymer and dyestuff intermediates 4,4'-methylenebis(N,N-dimethyl)-benzenamine, 4,4'-oxydianiline, and 4,4'-methylenedianiline.
    Weisburger EK; Murthy AS; Lilja HS; Lamb JC
    J Natl Cancer Inst; 1984 Jun; 72(6):1457-63. PubMed ID: 6587162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combined prophylactic administration of riboxin and algisorbum at 239Pu intake into gastrointestinal tract of rats].
    Vernigorova LA; Zhorova ES; Popov BA; Parfenova IM
    Radiats Biol Radioecol; 2005; 45(2):201-6. PubMed ID: 15906862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of complamine, nonachlazine, riboxine and clofeline on the fibrinogen content and fibrinolytic activity of the blood].
    Kremneva VF; Shevchenko LV
    Farmakol Toksikol; 1980; 43(3):330-5. PubMed ID: 7449972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments.
    Peto R; Pike MC; Day NE; Gray RG; Lee PN; Parish S; Peto J; Richards S; Wahrendorf J
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):311-426. PubMed ID: 6935185
    [No Abstract]   [Full Text] [Related]  

  • 39. [Potential blastomogenic properties of gardona].
    Didenko GG; Gupalovich TD; Petrovskaia OG
    Gig Sanit; 1984 May; (5):83-4. PubMed ID: 6468965
    [No Abstract]   [Full Text] [Related]  

  • 40. A measure of tumorigenic potency incorporating dose-response shape.
    Meier KL; Bailer AJ; Portier CJ
    Biometrics; 1993 Sep; 49(3):917-26. PubMed ID: 8241378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.